Literature DB >> 331419

Multiple primary malignant neoplasms. The Connecticut experience, 1935-1964.

B S Schoenberg.   

Abstract

Results for non-simultaneously diagnosed malignant tumors from Connecticut indicate that individuals with one malignant neoplasm have 1.29 times the risk of developing a new independent primary tumor when compared to individuals who never had cancer (P less than 0.01). However, the increased risk of multiple primary tumors is highly selective on a site-specific basis. Table 135 presents Connecticut Registry data indicating the risk of a subsequent primary malignancy by anatomic site of the later primary in patients with a first primary cancer. Tables 136 and 137 present tabulations for anatomic sites with statistically significant excesses and deficiencies, with an analysis by time interval between the two malignancies. Finally, Table 138 presents figures showing histologic confirmation for site-group paris with significant excesses of observed-over-expected later primary malignant neoplasms. The reader should bear in mind that just as the risk of subsequent primaries varies with the anatomic site of the subsequent primary (Table 135), the risk is also highly dependent upon the anatomic site of the first primary cancer (Chapters 6-12).

Entities:  

Mesh:

Year:  1977        PMID: 331419

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  10 in total

1.  Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice.

Authors:  Moshe Elkabets; Ann M Gifford; Christina Scheel; Bjorn Nilsson; Ferenc Reinhardt; Mark-Anthony Bray; Anne E Carpenter; Karin Jirström; Kristina Magnusson; Benjamin L Ebert; Fredrik Pontén; Robert A Weinberg; Sandra S McAllister
Journal:  J Clin Invest       Date:  2011-01-25       Impact factor: 14.808

2.  Synchronous bilateral breast cancer in a male patient following hormone therapy for prostate cancer.

Authors:  Yuko Kijima; Heiji Yoshinaka; Munetsugu Hirata; Yoshihisa Umekita; Sumika Matsukita; Takashi Arima; Masayuki Nakagawa; Hizuru Kumemura; Nobuo Hamada; Koichi Kaneko; Yawara Funasako; Shoji Natsugoe
Journal:  Int J Clin Oncol       Date:  2009-07-11       Impact factor: 3.402

3.  Multiple Primary Malignancies With Hypercalcemia Presentation: A Case Report.

Authors:  Sushmitha Diraviam; Asseel Al-Bayati; Oksana Mayovska; Rabhea Chaudhry; Swapnil V Patel
Journal:  Cureus       Date:  2022-04-19

4.  Case report of concurrent primary malignancies of the breast and nasopharynx.

Authors:  Xinbin Pan; Xiaodong Zhu; Qingdi Quentin Li
Journal:  Oncol Lett       Date:  2012-05-15       Impact factor: 2.967

5.  Multiple primary malignancies: a report of two cases.

Authors:  Minas Sakellakis; Stavros Peroukides; Gregoris Iconomou; Sotirios Boumpoucheropoulos; Haralabos Kalofonos
Journal:  Chin J Cancer Res       Date:  2014-04       Impact factor: 5.087

6.  [Morphologic distribution of tumors occuring in the canton of Vaud].

Authors:  B Junod; F Lévi
Journal:  Soz Praventivmed       Date:  1978-08

7.  A Descriptive Study of the Types and Survival Patterns of Saudi Patients with Multiple Primary Solid Malignancies: A 30-Year Tertiary Care Center Experience.

Authors:  Moustafa S Alhamadh; Rakan B Alanazi; Sultan T Algarni; Ahmed Abdullah R Alhuntushi; Mohammed Qasim Alshehri; Yusra Sajid Chachar; Mohammad Alkaiyat; Fouad Sabatin
Journal:  Curr Oncol       Date:  2022-07-13       Impact factor: 3.109

8.  Multiple primary tumours in women with vulvar neoplasms: a case-control study.

Authors:  K J Sherman; J R Daling; J Chu; B McKnight; N S Weiss
Journal:  Br J Cancer       Date:  1988-04       Impact factor: 7.640

9.  Multiple cancers. Tumor burden permits the outgrowth of other cancers.

Authors:  C A Mullen; J L Urban; C Van Waes; D A Rowley; H Schreiber
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

10.  Case Report: Synchronous primary malignancy including the breast and endometrium.

Authors:  Elham Sadat Banimostafavi; Sepideh Tayebi; Maryam Tayebi; Fatemeh Montazer
Journal:  F1000Res       Date:  2017-08-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.